Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 4/20 | 0.57 |
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 4/20 | 0.42 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9049667 | 1.00 | PPARA (0.57) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL41948 | 0.81 | — | — | |
| SCHEMBL3803007 | 0.81 | PPARA (0.55) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL3792243 | 0.79 | PPARA (0.53) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL10892940 | 0.77 | PPARA (0.91) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL3792249 | 0.77 | PPARA (0.91) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL5256485 | 0.77 | PPARA (0.67) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL27500497 | 0.77 | PPARA (0.67) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL9285865 | 0.77 | PPARA (0.91) | PPARACA2CA1EPHX1CA12 | |
| SCHEMBL7757406 | 0.75 | CA2 (0.65) | PPARACA2CA1EPHX1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9831042-B2 | Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells | BASF SE (DE) | 2017-11-28 | — | — | US | disclosed |
| US-20160126022-A1 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | BASF SE (DE) | 2016-05-05 | — | — | US | disclosed |
| EP-2870204-A2 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | BASF SE (DE) | 2015-05-13 | — | — | EP | disclosed |
| WO-2014006544-A2 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | BASF SE (DE) | 2014-01-09 | — | — | WO | disclosed |
| US-20100140559-A1 | MIXTURES FOR PRODUCING PHOTOACTIVE LAYERS FOR ORGANIC SOLAR CELLS AND ORGANIC PHOTODETECTORS | BASF SE (DE) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126022-A1 | ORGANIC DYES COMPRISING A HYDRAZONE MOIETY AND THEIR USE IN DYE-SENSITIZED SOLAR CELLS | C1S, C9, C1R | PPARA 4641/4885CA2 174/4885CA1 294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.